Amedisys to Present at 2007 BMO Capital Markets Focus on Healthcare Conference i... ( BATON ROUGE La. Nov. 28 /- Amedis...)

Amedisys to Present at 2007 BMO Capital Markets Focus on Healthcare Conference in New York

Date:11/28/2007

BATON ROUGE, La., Nov. 28 /PRNewswire-FirstCall/ -- Amedisys, Inc. (Nasdaq: "AMED" or the "Company"), one of America's leading home health nursing companies, today announced that Larry R. Graham, President and Chief Operating Officer, and Dale E. Redman, Chief Financial Officer, will present at the 2007 BMO Capital Markets Focus on Healthcare Conference in New York on Tuesday, December 4, 2007.

The presentation will begin at 2:30 p.m. Eastern time. The audio presentation will be webcast live and will be available at the following web address:

http://www.bmocm.com/conferences/2007healthcare/

Amedisys, Inc. is headquartered in Baton Rouge, Louisiana. Its common stock trades on the Nasdaq Global Select Market under the symbol "AMED".

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward- looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.

Additional information on the Company can be found at: http://www.amedisys.com

Contact: Amedisys, Inc. Amedisys, Inc.

Director of Investor Relations Senior V
'/>"/>

SOURCE Amedisys, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results
2. Amedisys Reports Record Third Quarter Revenue and Earnings
3. Amedisys to Present at 2007 CIBC Healthcare Conference in New York
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference

Post Your Comments:

(Date:5/23/2013)... News) -- A modified version of the polio ... preliminary research suggests. Scientists at Duke Cancer ... PVSRIPO, uses an engineered form of the virus ... cancer cells. The therapy shows promise in the ... brain tumor, they said. "These early results ...

(Date:5/23/2013)... (May 23, 2013)Don,t doubt it when a woman harried ... remembering things. A new study published online in ... Society (NAMS), helps confirm with objective tests that what ... In the past, some studies showed that hot flashes ... studies showed that, even though there was a relationship ...

(Date:5/23/2013)... PA (PRWEB) May 23, 2013 ... Teaching Site, offering a comprehensive babysitting training course for ... program was developed by Indianapolis pediatrician Dr. Patricia Keener ... the care of an adult sitter who didn’t know ... well-rounded youth development program with a medical basis that ...

(Date:5/23/2013)... anti-cancer drug about to be tested in a clinical ... possible treatment for Alzheimer,s disease has failed to work ... Alzheimer,s patients, according to results of a study by ... professor of neuroscience affiliated with the Evelyn F. and ... Florida, emphasized the importance of verifying promising research results ...

(Date:5/23/2013)... The Rottenstein Law Group LLP, a New York-based nationwide ... Information Center at http://www.rotlaw.com/tylenol , dedicated to issues ... considering filing lawsuits. , The painkiller Tylenol (acetaminophen) ... according to a 2009 report from the U.S. Food ... FDA warned consumers against using more than the recommended ...

Breaking Medicine News(10 mins):Health News:Modified Polio Virus May Help Fight Brain Tumors, Study Suggests 2 Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 2 Health News:Susquehanna Health Offers Safe Sitter Course for Tweens and Teens 3 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2 Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3 Health News:Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center 2

[0] Modified Polio Virus May Help Fight Brain Tumors, Study Suggests [0] It's not your imagination: Memory gets muddled at menopause [0] Susquehanna Health Offers Safe Sitter Course for Tweens and Teens [0] Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study [0] Rottenstein Law Group LLP Now Accepting Tylenol Cases, Announces New Tylenol Lawsuit Information Center

... , ... new market research report is available in its catalogue: ... , http://www.reportlinker.com/p0166825/Antibiotic-Resistance-and-Antibiotic-Technologies-Global-Markets.html , Provide an in-depth ... antibiotics technologies , Offer an analysis of antibiotics resistance ...

... , WEDNESDAY, Dec. 2 (HealthDay News) -- In the ... patients in the United States have improved modestly, a ... more than 100,000 patients diagnosed with stage 4 non-small ... patient information was in the U.S. National Cancer Institute,s ...

... have metabolic syndrome, study finds , WEDNESDAY, Dec. 2 ... overweight college football players from being at higher risk ... disease, a new study suggests. , Researchers studied linemen ... obese. Of those, 42 percent had metabolic syndrome, a ...

... Va., Dec. 2 By now, most people have heard of ... the latest product on the market is now available at the ... at the amazingly low price of $14.99. , "This new product ... very low price, before making a bigger investment in a smokeless ...

... MONTREAL, Dec. 2 /PRNewswire/ - As part of its continued ... part of Pfizer, has pledged more than 40 million international ... Hemophilia (WFH). This is the largest donation ever made to ... impact to advance the WFH,s goals. , "This donation will ...

... , KNOXVILLE, Tenn., Dec. 2 TeamHealth ( www.teamhealth.com ... of Naples-based Emergency Physicians of Naples, LLC (EPN). Since ... Healthcare System to staff the emergency facilities at the Downtown ... EPN also provides the staffing for two stand-alone urgent care ...

Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets Gains Made in Lung Cancer Survival Oversized College Football Players May Face Heart Risks A Smokeless Holiday Season? Premium Electronic Cigarette Announces New Disposable Smokeless Cigarette Product The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH TeamHealth Acquires Emergency Physicians of Naples, LLC

(Date:5/23/2013)... , May 23, 2013 Israel Brain ... 2013 , Israel,s 1 st ... 14 th -15 th in Tel Aviv ... innovative city in the world by the Wall Street ... BrainTech Israel 2013 will showcase the latest breakthroughs in ...

(Date:5/23/2013)... , May 23, 2013 EarlySense, ... today that the prize for ,Best Novel Idea, at ... Medical Emergency Teams International Conference, hosted this year in ... awarded to a clinical research team studying the impact ... Hospital in Los Angeles . The ...

(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ( ... FDA, Health Canada and CE ( Europe ... Glasgow Science Centre in Scotland , ... the SynCardia temporary Total Artificial Heart powered ... $3 million Bodyworks Exhibition, one of the most advanced ...

Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2 Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3 Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 2 Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 3 Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference 4 Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 2 Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition 3

[0] Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference [0] Clinical Team Researching the Impact of the EarlySense System Wins 'Best Novel Idea' Prize at the Rapid Response Systems and Medical Emergency Teams 2013 8th International Conference [0] Glasgow Science Centre Features SynCardia Total Artificial Heart in $3 Million Exhibition

... -- , - Cipralex Better Tolerated and at ... A/S announces new study data published today in ... (escitalopram) was superior to duloxetine in the acute,treatment ... was,at least as efficacious in long-term treatment(1). The ...

... for CPX-1 presented at ASCO confirm safety findings,and ... patients with,colorectal and other types of cancer., PRINCETON, ... positive safety and efficacy results from,its Phase I ... with heavily pre-treated, advanced solid,tumors. Results were presented ...

Cached Medicine Technology:Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 2 Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 3 Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 4 Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 5 Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 2 Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing 3

Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression Celator Pharmaceuticals Study Shows Anti-Tumor Activity in Cancer,Patients Treated with Therapy Based on Ratiometric Dosing

... Ultra Strep A Test is a color ... DLT uses antibody labeled color particles coated ... device. DLT allows greater sensitivity than the ... In the test procedure, a throat swab ...

... Fertell test is an easy to use, one ... reserve by means of determining the amount of ... sample. The test is performed two days after ... menstrual cycle) and is similar in design and ...

... The Cholestech GDX System delivers an unmatched combination ... ideal solution for assessing and monitoring a patient's ... demo, click here ., ,The CLIA-waived Cholestech ... A1C results in less than 5 minutes. The ...

... The Cholestech LDX System, using patented, ... plus glucose and ALT in only 5 ... new ALT test, you can get immediate ... measurement capabilities is not the only advantage ...

Medicine Products:

OSOM Ultra 25 Strep A Fertell Female Fertility Test Cholestech GDX System LDX Analyzer